newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics Announces Publication of DM199's Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke

Scientific insight into DM199's mechanism for increasing collateral circulation and salvaging brain tissue at-risk from infarction DiaMedica Therapeutics Inc. (NASDAQ:DMAC), a clinical-stage biopharmaceutical company